Published in PLoS One on November 08, 2011
Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice. Front Oncol (2013) 0.99
A systems biology view of blood vessel growth and remodelling. J Cell Mol Med (2013) 0.86
Antiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells. Onco Targets Ther (2014) 0.83
Serum-dependence of affinity-mediated VEGF release from biomimetic microspheres. Biomacromolecules (2014) 0.80
Zymographic and ultrastructural evaluations after low-level laser irradiation on masseter muscle of HRS/J strain mice. Lasers Med Sci (2012) 0.77
Negative pressure wound therapy induces early wound healing by increased and accelerated expression of vascular endothelial growth factor receptors. Eur J Plast Surg (2016) 0.75
Deterministic and Stochastic Study for a Microscopic Angiogenesis Model: Applications to the Lewis Lung Carcinoma. PLoS One (2016) 0.75
Monitoring Severity of Multiple Organ Dysfunction Syndrome: New Technologies. Pediatr Crit Care Med (2017) 0.75
A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF165b in peripheral arterial disease in human and mouse. Sci Rep (2016) 0.75
A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands. PLoS Comput Biol (2017) 0.75
CLINICAL STUDIES OF THE BLOOD VOLUME. II. THE RELATION OF PLASMA AND TOTAL BLOOD VOLUME TO VENOUS PRESSURE, BLOOD VELOCITY RATE, PHYSICAL MEASUREMENTS, AGE AND SEX IN NINETY NORMAL HUMANS. J Clin Invest (1937) 47.11
The biology of VEGF and its receptors. Nat Med (2003) 32.13
Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med (1995) 26.60
Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (1989) 16.71
The biology of vascular endothelial growth factor. Endocr Rev (1997) 13.70
VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A (2002) 8.10
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem (1992) 4.92
Heterotransplantation of a human malignant tumour to "Nude" mice. Acta Pathol Microbiol Scand (1969) 4.07
Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood (2007) 3.38
Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem (2003) 3.36
Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol (2007) 2.62
Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn (2001) 2.53
Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am J Physiol Renal Physiol (2005) 2.34
VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade. Proc Natl Acad Sci U S A (2007) 2.19
Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood (2006) 1.88
Modeling the early stages of vascular network assembly. EMBO J (2003) 1.78
Expression of myostatin pro domain results in muscular transgenic mice. Mol Reprod Dev (2001) 1.66
A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J Cell Mol Med (2009) 1.59
VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma. Int J Radiat Oncol Biol Phys (2007) 1.55
Transport of large molecules from plasma to interstitial fluid and lymph in dogs. Am J Physiol (1970) 1.52
Morphology favors an endothelial cell pathway for longitudinal conduction within arterioles. Microvasc Res (1997) 1.51
A compartment model of VEGF distribution in blood, healthy and diseased tissues. BMC Syst Biol (2008) 1.50
Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem (2000) 1.41
Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol Genomics (2004) 1.40
Integrated approach to designing growth factor delivery systems. FASEB J (2007) 1.35
Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. J Physiol (2009) 1.32
Distribution of myonuclei and microtubules in live muscle fibers of young, middle-aged, and old mice. J Appl Physiol (1985) (2006) 1.24
Structural and hemodynamic analysis of the mouse retinal microcirculation. Invest Ophthalmol Vis Sci (2003) 1.23
Increase of plasma VEGF after intravenous administration of bevacizumab is predicted by a pharmacokinetic model. Cancer Res (2010) 1.22
Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle. Am J Physiol Heart Circ Physiol (2006) 1.21
A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung. J Thorac Oncol (2010) 1.16
Quantification and cell-to-cell variation of vascular endothelial growth factor receptors. Exp Cell Res (2010) 1.14
Myonuclear domain size and myosin isoform expression in muscle fibres from mammals representing a 100,000-fold difference in body size. Exp Physiol (2008) 1.12
A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap. PLoS One (2009) 1.09
Continuous monitoring of blood volume changes in humans. J Appl Physiol (1985) (1987) 1.05
Module-based multiscale simulation of angiogenesis in skeletal muscle. Theor Biol Med Model (2011) 1.04
Fibre type composition of soleus and extensor digitorum longus muscles in normal female inbred Lewis rats. Acta Histochem (2002) 1.03
A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors. Ann Biomed Eng (2004) 1.02
Vascular endothelial growth factors in cardiovascular medicine. J Cardiovasc Med (Hagerstown) (2008) 0.97
The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling. PLoS Comput Biol (2009) 0.96
Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. J Appl Physiol (1985) (2005) 0.95
Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis. BMC Syst Biol (2011) 0.94
VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model. Am J Physiol Heart Circ Physiol (2010) 0.93
Capillary changes in skeletal muscle of patients with essential hypertension. Anat Rec (1999) 0.93
Release kinetics of VEGF165 from a collagen matrix and structural matrix changes in a circulation model. Head Face Med (2010) 0.92
Pathological significance of vascular endothelial growth factor A isoform expression in human cancer. Pathol Int (2002) 0.91
Anatomic capillarization is elevated in the medial gastrocnemius muscle of mighty mini mice. J Appl Physiol (1985) (2009) 0.88
Computational models of VEGF-associated angiogenic processes in cancer. Math Med Biol (2011) 0.87
Integration of angiogenesis modules at multiple scales: from molecular to tissue. Pac Symp Biocomput (2009) 0.87
The time course of myonuclear accretion during hypertrophy in young adult and older rat plantaris muscle. Ann Anat (2010) 0.87
Epo is relevant neither for microvascular formation nor for the new formation and maintenance of mice skeletal muscle fibres in both normoxia and hypoxia. J Biomed Biotechnol (2010) 0.87
Interstitial space of mouse skeletal muscle. J Physiol (1982) 0.86
Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women. Pol J Pathol (2002) 0.85
Skeletal muscle fiber types in the adult mouse. Acta Neurol Scand (1976) 0.85
Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma. Pol J Pathol (2003) 0.84
Skin capillary metrics and hemodynamics in the hairless mouse. Microvasc Res (1992) 0.84
Effect of exercise training and carvedilol treatment on cardiac function and structure in mice with sympathetic hyperactivity-induced heart failure. Braz J Med Biol Res (2008) 0.84
Lymphatic absorption of fatty acids and cholesterol in the neonatal rat. Am J Physiol Gastrointest Liver Physiol (2000) 0.83
Muscle capillary tortuosity in high altitude mice depends on sarcomere length. Respir Physiol (1989) 0.83
Capillary supply and gene expression of angiogenesis-related factors in murine skeletal muscle following denervation. Exp Physiol (2005) 0.83
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane. Clin Breast Cancer (2012) 0.82
Basement membrane and interstitial collagen content of whole animals and tissues. Biochem Biophys Res Commun (1975) 0.82
Densities of collagen dehydrated by some organic solvents. Experientia (1966) 0.82
Anatomy of the mouse retina. Capillary basement membrane thickness. Invest Ophthalmol Vis Sci (1986) 0.81
Age-related changes in rat brain capillaries. Neurobiol Aging (1983) 0.80
Aberrant isoform of vascular endothelial growth factor 189 expression is correlated with xenotransplantability of human esophageal cancer. Oncol Rep (1998) 0.80
Lymph esterases of the house mouse (Mus musculus)--II. The role of esterase-2 in fat resorption. Comp Biochem Physiol B (1988) 0.80
Modeling of growth factor-receptor systems from molecular-level protein interaction networks to whole-body compartment models. Methods Enzymol (2009) 0.77
Width of retinal capillary basement membrane of spiny mice (Acomy cahirinus) at various ages. Doc Ophthalmol (1970) 0.76
Diet and starvation on the composition and calculated density of fat-free body mass. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.76
Determination of plasma volume in the mouse with screened iodine-labelled proteins. Experientia (1968) 0.76
Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions. J Natl Cancer Inst (2013) 1.75
A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J Cell Mol Med (2009) 1.59
A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2. J Biol Chem (2004) 1.51
A compartment model of VEGF distribution in blood, healthy and diseased tissues. BMC Syst Biol (2008) 1.50
Temporal and spatial variations of cell-free layer width in arterioles. Am J Physiol Heart Circ Physiol (2007) 1.46
Systems biology of vascular endothelial growth factors. Microcirculation (2008) 1.41
Computational fluid dynamic simulation of aggregation of deformable cells in a shear flow. J Biomech Eng (2005) 1.40
Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells. Am J Physiol Heart Circ Physiol (2003) 1.33
Anti-angiogenic peptides for cancer therapeutics. Curr Pharm Biotechnol (2011) 1.32
Multiscale models of angiogenesis. IEEE Eng Med Biol Mag (2009) 1.26
Effects of erythrocyte deformability and aggregation on the cell free layer and apparent viscosity of microscopic blood flows. Microvasc Res (2009) 1.24
Increase of plasma VEGF after intravenous administration of bevacizumab is predicted by a pharmacokinetic model. Cancer Res (2010) 1.22
Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia. Mol Cell Biol (2008) 1.21
Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle. Am J Physiol Heart Circ Physiol (2006) 1.21
Effect of aggregation and shear rate on the dispersion of red blood cells flowing in venules. Am J Physiol Heart Circ Physiol (2002) 1.20
A computational model of intracellular oxygen sensing by hypoxia-inducible factor HIF1 alpha. J Cell Sci (2006) 1.20
VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle. J Appl Physiol (1985) (2006) 1.20
Blood flow and cell-free layer in microvessels. Microcirculation (2010) 1.19
A biochemical model of matrix metalloproteinase 9 activation and inhibition. J Biol Chem (2007) 1.18
Experimental and theoretical studies of oxygen gradients in rat pial microvessels. J Cereb Blood Flow Metab (2008) 1.18
Dimerization of VEGF receptors and implications for signal transduction: a computational study. Biophys Chem (2007) 1.18
Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches. PLoS Comput Biol (2006) 1.17
A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells. Proc Natl Acad Sci U S A (2008) 1.16
Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective. Antioxid Redox Signal (2008) 1.16
Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model. J Theor Biol (2005) 1.16
Theoretical analysis of biochemical pathways of nitric oxide release from vascular endothelial cells. Free Radic Biol Med (2006) 1.15
Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms. AAPS J (2012) 1.14
Red blood cell aggregation and dissociation in shear flows simulated by lattice Boltzmann method. J Biomech (2007) 1.14
Quantification and cell-to-cell variation of vascular endothelial growth factor receptors. Exp Cell Res (2010) 1.14
Effect of outer hair cell piezoelectricity on high-frequency receptor potentials. J Acoust Soc Am (2003) 1.13
Erythrocyte consumption of nitric oxide in presence and absence of plasma-based hemoglobin. Am J Physiol Heart Circ Physiol (2002) 1.13
Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model. Am J Physiol Heart Circ Physiol (2005) 1.11
Elongation, proliferation & migration differentiate endothelial cell phenotypes and determine capillary sprouting. BMC Syst Biol (2009) 1.10
Computational model of vascular endothelial growth factor spatial distribution in muscle and pro-angiogenic cell therapy. PLoS Comput Biol (2006) 1.10
Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts. Neoplasia (2009) 1.10
A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap. PLoS One (2009) 1.09
Contribution of nNOS- and eNOS-derived NO to microvascular smooth muscle NO exposure. J Appl Physiol (1985) (2004) 1.07
Systems biology of pro-angiogenic therapies targeting the VEGF system. Wiley Interdiscip Rev Syst Biol Med (2010) 1.06
A computer-based method for determination of the cell-free layer width in microcirculation. Microcirculation (2006) 1.06
Wall shear stress differentially affects NO level in arterioles for volume expanders and Hb-based O2 carriers. Microvasc Res (2003) 1.05
Module-based multiscale simulation of angiogenesis in skeletal muscle. Theor Biol Med Model (2011) 1.04
Nitric oxide from nitrite reduction by hemoglobin in the plasma and erythrocytes. Nitric Oxide (2007) 1.03
Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes. Am J Physiol Heart Circ Physiol (2002) 1.03
Multi-scale computational models of pro-angiogenic treatments in peripheral arterial disease. Ann Biomed Eng (2007) 1.03
Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties. Biochem Biophys Res Commun (2007) 1.03
A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors. Ann Biomed Eng (2004) 1.02
Calculations of oxygen transport by red blood cells and hemoglobin solutions in capillaries. Artif Cells Blood Substit Immobil Biotechnol (2002) 1.00
Relationship between erythrocyte aggregate size and flow rate in skeletal muscle venules. Am J Physiol Heart Circ Physiol (2003) 1.00
A computational model of oxygen transport in skeletal muscle for sprouting and splitting modes of angiogenesis. J Theor Biol (2006) 1.00
Intracoronary administration of FGF-2: a computational model of myocardial deposition and retention. Am J Physiol Heart Circ Physiol (2004) 1.00
Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice. Front Oncol (2013) 0.99
A computational model of oxygen delivery by hemoglobin-based oxygen carriers in three-dimensional microvascular networks. J Theor Biol (2007) 0.98
Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies. BMC Syst Biol (2011) 0.98
Three autocrine feedback loops determine HIF1 alpha expression in chronic hypoxia. Biochim Biophys Acta (2007) 0.97
Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise. Am J Physiol Heart Circ Physiol (2007) 0.97
An immersed boundary lattice Boltzmann approach to simulate deformable liquid capsules and its application to microscopic blood flows. Phys Biol (2007) 0.97
Aggregate formation of erythrocytes in postcapillary venules. Am J Physiol Heart Circ Physiol (2004) 0.96
Theoretical models for coronary vascular biomechanics: progress & challenges. Prog Biophys Mol Biol (2010) 0.96
The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling. PLoS Comput Biol (2009) 0.96
Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A. Neoplasia (2013) 0.96
A theoretical model of nitric oxide transport in arterioles: frequency- vs. amplitude-dependent control of cGMP formation. Am J Physiol Heart Circ Physiol (2003) 0.94
Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis. BMC Syst Biol (2011) 0.94
Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation. Int J Biochem Cell Biol (2011) 0.94
Multiscale imaging and computational modeling of blood flow in the tumor vasculature. Ann Biomed Eng (2012) 0.94
Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model. BMC Cancer (2010) 0.93
Hypotonic swelling of salicylate-treated cochlear outer hair cells. Hear Res (2007) 0.93
VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model. Am J Physiol Heart Circ Physiol (2010) 0.93
Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts. Cancer Med (2014) 0.92
Vascular smooth muscle NO exposure from intraerythrocytic SNOHb: a mathematical model. Antioxid Redox Signal (2007) 0.92
Effect of erythrocyte aggregation at normal human levels on functional capillary density in rat spinotrapezius muscle. Am J Physiol Heart Circ Physiol (2005) 0.92
Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model. PLoS One (2010) 0.92
Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity. J Med Chem (2011) 0.91
An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator. Biotechnol Bioeng (2002) 0.90
Endothelial cell-by-cell profiling reveals the temporal dynamics of VEGFR1 and VEGFR2 membrane localization after murine hindlimb ischemia. Am J Physiol Heart Circ Physiol (2013) 0.90
A model of nitric oxide capillary exchange. Microcirculation (2003) 0.90
Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines. J Cell Biochem (2008) 0.90
Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport. Physiol Genomics (2009) 0.90
Expression of VEGF receptors on endothelial cells in mouse skeletal muscle. PLoS One (2012) 0.90
Anti-angiogenic peptides identified in thrombospondin type I domains. Biochem Biophys Res Commun (2007) 0.89
Blood-plasma separation in Y-shaped bifurcating microfluidic channels: a dissipative particle dynamics simulation study. Phys Biol (2012) 0.89
Monte Carlo simulations of VEGF binding to cell surface receptors in vitro. Biochim Biophys Acta (2005) 0.88
Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells. Int J Biochem Cell Biol (2007) 0.87
Gene therapy from the perspective of systems biology. Curr Opin Mol Ther (2010) 0.87
Analysis of VEGF--a regulated gene expression in endothelial cells to identify genes linked to angiogenesis. PLoS One (2011) 0.87
Integration of angiogenesis modules at multiple scales: from molecular to tissue. Pac Symp Biocomput (2009) 0.87
Trans-scleral delivery of antiangiogenic proteins. J Ocul Pharmacol Ther (2008) 0.87
Computational models of VEGF-associated angiogenic processes in cancer. Math Med Biol (2011) 0.87
Pre-treatment of mice with tumor-conditioned media accelerates metastasis to lymph nodes and lungs: a new spontaneous breast cancer metastasis model. Clin Exp Metastasis (2013) 0.87
Vascular and perivascular nitric oxide release and transport: biochemical pathways of neuronal nitric oxide synthase (NOS1) and endothelial nitric oxide synthase (NOS3). Free Radic Biol Med (2006) 0.87
Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer. Cancer Biol Ther (2011) 0.86
Protein transport to choroid and retina following periocular injection: theoretical and experimental study. Ann Biomed Eng (2007) 0.86
Systems biology and physiome projects. Wiley Interdiscip Rev Syst Biol Med (2010) 0.86
Effects of chlorpromazine on mechanical properties of the outer hair cell plasma membrane. Biophys J (2005) 0.86
Venular endothelium-derived NO can affect paired arteriole: a computational model. Am J Physiol Heart Circ Physiol (2005) 0.86
Computational analysis of the tether-pulling experiment to probe plasma membrane-cytoskeleton interaction in cells. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 0.86
A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization. Invest Ophthalmol Vis Sci (2009) 0.86
A systems biology view of blood vessel growth and remodelling. J Cell Mol Med (2013) 0.86